The influence of dapagliflozin on cardiac remodeling, myocardial function and metabolomics in type 1 diabetes mellitus rats.

Authors:
Rodrigues EA; Rosa CM; Campos DHS; Damatto FC; Murata GM and 10 more

Journal:
Diabetol Metab Syndr

Publication Year: 2023

DOI:
10.1186/s13098-023-01196-6

PMCID:
PMC10617150

PMID:
37908006

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Diabetol Metab Syndr

Abbreviation: Diabetol Metab Syndr

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Endocrinology & Metabolism

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
2024 UPDATE: the Brazilian Diabetes Society position on the management of metabolic dysfunction-ass…
Godoy-Matos AF; Valério CM; Silva Júnior WS and 2 more (2024) - Transparency Score: 3/6
A comparative study of cardiovascular risk stratification methods in type 1 diabetes mellitus patie…
de Araujo FM; Comim FV; Lamounier RN and 5 more (2024) - Transparency Score: 3/6
Anthropometric parameters as a tool for the prediction of metabolic and cardiovascular risk in chil…
Romano A; Masino M; Rivetti S and 4 more (2024) - Transparency Score: 3/6
Clinical inertia in newly diagnosed type 2 diabetes mellitus among patients attending selected heal…
Alvis-Guzman N; Romero M; Salcedo-Mejia F and 9 more (2024) - Transparency Score: 3/6
Clinical outcomes of simultaneous pancreas-kidney transplantation in elderly type II diabetic recip…
Cao Y; Zhao J; Feng G and 5 more (2024) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Ethics approval and consent to participateAll experiments and procedures were approved by the Animal Ethics Committee of Botucatu Medical School (nº 1320/2019), Sao Paulo State University, UNESP, Botucatu, SP, Brazil. Consent to PublishNot Applicable. Competing interestsThe authors declare that they have no competing interests. Competing interests The authors declare that they have no competing interests."

Evidence found in paper:

"Funding This research was funded by CNPq (Proc. n. 140400/2019-2; 307703/2022-3; and 307280/ 2022-5), FAPESP (Proc. n. 2021/10923-5), and PROPe, UNESP."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025